BFRT in Adolescents After ACL Reconstruction

Background: Approximately 100,000 anterior cruciate ligament reconstructions (ACLR) are performed yearly, and rates of these surgeries in patients younger than 15 years increased by 924% between 1990 and 2007.1 Persistent strength deficits in quadriceps musculature following ACLR are common, even several months after surgery and despite targeted physical therapy to address atrophy.2 Quadriceps atrophy and weakness are associated with worse patient-reported outcomes (PROs),3 as well as altered movement strategies and increased risk of reinjury.4,6 Approximately 20% of teenagers returning to sports will sustain a second ACL injury in the first two years following their ACLR.5 Regaining neuromuscular activation and strength of the quadriceps muscle safely and efficiently is vital to full recovery, and current post-operative physical therapy regimens have not sufficiently addressed this impairment. Strength training models recommend utilizing high resistance workloads to produce substantial strength gains,7 yet those recovering from orthopedic surgery are unable to tolerate heavy loads.8 Supplementing low-load resistance training with blood flow restriction (BFR-LLT) produces significant muscle hypertrophy and strength gains previously only thought to be achievable with high-load resistance training.9 BFR-LLT uses a tourniquet around the leg (see Appendix 4) to partially occlude venous return and decrease blood supply to the muscle being exercised. The generation of a low-oxygen environment and increases in plasma growth hormone levels has been shown to promote recruitment of motor units, improve neuromuscular activation, and result in muscular hypertrophy and growth.10-13 In adults and the elderly, improvements in quadriceps strength have been reported in up to 19%14 and increased quadriceps cross-sectional area in up to 6-7% compared to controls.15-16 To date there have only been four high-level studies investigating effects of BFR training in patients following ACLR17-20 and limited conclusions can be drawn from these studies due to lack of consistent methodology (variable cuff pressures and treatment frequency). More high-quality research is needed to determine treatment parameters that produce the most optimal results from this intervention in ACLR patients. Additionally, there are no published randomized controlled trials investigating the effects of BFR training on exclusively adolescent patients. All high-quality BFR training research in patients following knee surgery have been conducted in late adolescent, young adult and adult populations.17-21 Therefore, the purpose of this study is to assess the effect of BFR-LLT on quadriceps strength and outcomes in adolescents following ACLR. This study's adolescent-specific focus provides a significant contribution to ACLR research, as younger patients demonstrate higher risk of reinjury.22-24 The results from this preliminary study will ultimately provide data to guide clinicians in optimizing quadriceps strength and utilizing BFR-LLT in younger post-operative ACLR patients. Protocol: This randomized clinical trial is an interdisciplinary project between the CHOA Sports Medicine Physical Therapy department and Children's Physician Group (CPG) Orthopedics. As part of standard-of-care, all patients who plan to undergo ACLR by CPG Orthopedics surgeons are referred for at least one PT visit pre-surgery, at which time baseline strength measurements are obtained by the treating physical therapist. Pre-surgery collection of patient-reported outcomes (PROs) is also standard of care for all patients undergoing ACLR. Skeletally mature male and female adolescents with closed growth plates documented by radiograph who undergo ACLR with quadriceps tendon autograft will be screened by a physical therapist (the PI or co-investigators) using medical notes. If a patient meets criteria and consents, he/she will be enrolled into the study during the first routine-of-care post-surgery PT visit and randomized to undergo standard post-surgery rehabilitation (control group) or standard post-surgery rehabilitation with supplemental BFR-LLT (test group) as demonstrated in Figure 1 and Appendix 1. Participants will be randomized using a computer program that will generate random numbers to assign participants to the test group or the control group. Participants will be asked to complete four PROs throughout the study (Lysholm, Pedi-IKDC, ACL-RSI, and AMCaMP - see Appendix 5.1-5.4). All relevant demographic, physiological, and radiographic data will be collected at the time of enrollment via RedCap, through a secure link. Data will be stored in a password-protected file on a secure Children's server and only the PI, Co-investigators, and research coordinator will have access. Eight physical therapists (all CITI-trained) at four sports medicine PT sites will oversee all post-surgery PT sessions. Participants in the control group will follow a standard post-surgery rehabilitation protocol starting 2-5 days post-surgery and attend two PT visits per week until 16 weeks post-surgery. The test group will follow an identical schedule of PT visits but will have two to three exercises in each session supplemented with BFR treatment using the Delfi Personalized Tourniquet System (PTS). Requirements of BFR treatment are described below. For both groups, each session will last approximately 60 minutes. Each of the exercises performed with BFR will last 5-18 minutes, with total time under occlusion not exceeding 30 minutes per visit. Participants undergoing BFR treatment will wear limb protection sleeves designed to help protect the skin beneath the cuff while the cuff is pressurized. Skin integrity will be monitored pre- and post-treatment at each session. If a study participant reports intolerable pain levels during BFR, the physical therapist will fully deflate the cuff and BFR treatment will cease for that PT session. Any adverse events will be reported to the PI and Co-I's within 24 hours. All required medical assessments will be promptly performed. If a participant is assigned to the test group, BFR intervention will end after 16 weeks post-surgery. Both the test group (BFR-LLT) and the control group will follow standard of care treatment after week 16 post-surgery, including the standard post-intervention functional testing at 24 weeks post-surgery. Participants will be asked to complete PROs periodically throughout the study as listed below under data collection. All physical examination measures and testing listed are standard of care for ACLR rehabilitation patients. Details on the regimen followed by both cohorts during the full 6-month rehabilitation are outlined in Appendix 1. BFR-LLT Treatment Requirements: The BFR-LLT intervention requires participants to follow the two requirements listed below, as the treatment parameter of 80% LOP has been widely recommended as the ideal amount of blood flow occlusion throughout the literature. Participants who do not meet these criteria will be excluded from the study but will continue to receive standard of care for post-surgery ACLR rehabilitation. 1. Tolerate a personalized pressure of 80% of the limb occlusion pressure (LOP) for 100% of all physical therapy visits in which BFR-LLT is utilized. 2. Tolerate BFR-LLT for a minimum of 20 visits over 16 weeks. Data Collection: 1. Demographic data (pre-surgery, which is standard of care) will include age, gender, race/ethnicity, height/weight, physeal status, and assessment of baseline activity level with the Tegner Activity Scale (see Appendix 6) 2. Patient-reported outcomes (PROs) (see Appendix 5) will include the Pediatric Internal Knee Documentation Committee (Pedi-IKDC, Appendix 5.1), Lysholm Score (Appendix 5.2), ACL-Return to Sport after Injury (ACL-RSI) confidence assessment (Appendix 5.3) and Adolescent Measure of Confidence and Musculoskeletal Performance (AMCaMP,Appendix 5.4). These PROs are collected pre-surgery as standard of care, but further collection and reassessment of PROs as described in Figure 2 will be unique to study participants. Surveys will be collected and recorded on iPads with direct entry into REDCap and in each participant's confidential EHR on the treatment note from the day the data was collected. All responses will be stored on a secure RedCap server through a secure link and data will be stored in a password-protected file on a secure Children's server. Only the PI and Co-I's will have access to the data.